Yipinhong Pharmaceutical Co Ltd banner

Yipinhong Pharmaceutical Co Ltd
SZSE:300723

Watchlist Manager
Yipinhong Pharmaceutical Co Ltd Logo
Yipinhong Pharmaceutical Co Ltd
SZSE:300723
Watchlist
Price: 33.29 CNY -0.92% Market Closed
Market Cap: ¥15B

Net Margin

-41.9%
Current
Declining
by 28.2%
vs 3-y average of -13.7%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-41.9%
=
Net Income
¥-429.6m
/
Revenue
¥1B

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-41.9%
=
Net Income
¥-429.6m
/
Revenue
¥1B

Peer Comparison

Country Company Market Cap Net
Margin
CN
Yipinhong Pharmaceutical Co Ltd
SZSE:300723
15B CNY
Loading...
US
Eli Lilly and Co
NYSE:LLY
959.3B USD
Loading...
US
Johnson & Johnson
NYSE:JNJ
585.3B USD
Loading...
CH
Roche Holding AG
SIX:ROG
291.8B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
238.2B GBP
Loading...
CH
Novartis AG
SIX:NOVN
242.2B CHF
Loading...
US
Merck & Co Inc
NYSE:MRK
305.1B USD
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.3T DKK
Loading...
US
Pfizer Inc
NYSE:PFE
151.4B USD
Loading...
UK
GSK plc
XETRA:GS71
103.6B EUR
Loading...

Market Distribution

Lower than 90% of companies in China
Percentile
10th
Based on 8 721 companies
10th percentile
-41.9%
Low
-416 945.9% — -1.5%
Typical Range
-1.5% — 8.9%
High
8.9% — 17 382.1%
Distribution Statistics
China
Min -416 945.9%
30th Percentile -1.5%
Median 3.5%
70th Percentile 8.9%
Max 17 382.1%

Yipinhong Pharmaceutical Co Ltd
Glance View

Market Cap
15B CNY
Industry
Pharmaceuticals

Yipinhong Pharmaceutical Co Ltd has carved its niche in the pharmaceutical landscape of China, with its roots embedded deeply in the nation's flourishing healthcare sector. Known for its dedication to combining traditional Chinese medicinal practices with modern scientific research, the company stands out in an increasingly competitive market. Yipinhong's operations are centered around developing, manufacturing, and distributing a broad spectrum of medicinal products that adhere to the highest quality standards. By focusing on therapeutic areas such as respiratory, cardiovascular, and gastrointestinal health, they strategically align with the growing demand for reliable medicinal solutions. What makes Yipinhong truly distinctive is its investment in research and development that drives innovation. This focus not only ensures a continuous pipeline of new products but positions them as a leader in the integration of traditional remedies with cutting-edge pharmaceutical science. The company thrives on a business model that maximizes its robust distribution network, encompassing both domestic and international markets. Yipinhong capitalizes on its vast network of sales agents and partnerships with hospitals, clinics, and pharmacies to ensure its products reach consumers efficiently. This network amplifies their revenue streams by tapping into various segments within the pharmaceutical supply chain. Moreover, Yipinhong's strategic collaborations for research and development and their participation in healthcare industry events bolster their market presence and brand recognition. By maintaining a harmonious balance between traditional approaches and modern demands, Yipinhong not only captures a unique market position but also sets a benchmark in pharmaceutical excellence and innovation.

Intrinsic Value
9.15 CNY
Overvaluation 73%
Intrinsic Value
Price
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
-41.9%
=
Net Income
¥-429.6m
/
Revenue
¥1B
What is Yipinhong Pharmaceutical Co Ltd's current Net Margin?

The current Net Margin for Yipinhong Pharmaceutical Co Ltd is -41.9%, which is below its 3-year median of -13.7%.

How has Net Margin changed over time?

Over the last 3 years, Yipinhong Pharmaceutical Co Ltd’s Net Margin has decreased from 13.2% to -41.9%. During this period, it reached a low of -58.9% on Jun 30, 2025 and a high of 13.2% on Aug 30, 2022.

Back to Top